Han-Lin Hsu

Dose escalation intensity-modulated radiotherapy–based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma

Chia-Lun Chang, Hsieh‐Chih Tsai, Wei-Cheng Lin et al. · Radiotherapy and Oncology · 2017 · 105 citations

Medicine, Oncology, Radiation Oncology +14

Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung Cancer

Hsin‐Lun Lee, Jeng-Fong Chiou, Peng‐Yuan Wang et al. · Cancers · 2020 · 46 citations · Full text

Medicine, Cancer Biology, Oncology +17

MicroRNA-224 Suppresses Colorectal Cancer Cell Migration by Targeting Cdc42

Tao‐Wei Ke, Han-Lin Hsu, Yu-Hua Wu et al. · Disease Markers · 2014 · 45 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Annexin A2 in renal cell carcinoma: Expression, function, and prognostic significance

Shun‐Fa Yang, Han-Lin Hsu, Tai‐Kuang Chao et al. · Urologic Oncology Seminars and Original Investigations · 2014 · 45 citations

Medicine, Cancer Biology, Oncology +12

Efficacy of thoracic radiotherapy in patients with stage IIIB–IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment

Yu‐Chun Yen, Han-Lin Hsu, Jer‐Hwa Chang et al. · Radiotherapy and Oncology · 2018 · 40 citations

Medicine, Oncology, Radiation Oncology +11